Tourmaline Bio CMO Dr. Yung Chyung resigns effective Oct 31, 2024

Tourmaline Bio, Inc.

Dr. Yung Chyung resigns as Chief Medical Officer effective October 31, 2024.
Resignation is voluntary to pursue other opportunity; no disagreement with company.
He will stay through Oct 31 to assist transition; duties assumed by senior management.
Company has initiated a search for his successor.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Yung Chyung

Chief Medical Officer

Tourmaline Bio, Inc.

Effective: 2024-10-31
Filed: October 10, 2024, 7:59 PM ET

On October 4, 2024, Dr. Yung Chyung gave notice of his decision to resign from his position as Chief Medical Officer of Tourmaline Bio, Inc. (the “Company”) in order to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Yung Chyung departed as Chief Medical Officer at Tourmaline Bio, Inc..

Action: resign
Role: Chief Medical Officer

Exact text from the filing

On October 4, 2024, Dr. Yung Chyung gave notice of his decision to resign from his position as Chief Medical Officer of Tourmaline Bio, Inc. (the “Company”) in order to pursue another opportunity.

View on SEC.gov

Source: SEC EDGAR

accession 0001827506-24-000086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.